{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T19:41:49Z","timestamp":1783539709075,"version":"3.55.0"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T00:00:00Z","timestamp":1638748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100007028","name":"Leona M. and Harry B. Helmsley Charitable Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007028","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Severe acute respiratory syndrome coronavirus 2 vaccination is recommended for all individuals with inflammatory bowel disease (IBD), including those on immunosuppressive therapies; however, little is known about vaccine safety and efficacy in these patients or the impact of vaccination on IBD disease course.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We evaluated coronavirus disease 2019 (COVID-19) vaccine\u2013related adverse events (AEs) and the effect of vaccination on IBD disease course among participants in the PREVENT-COVID (Partnership to Report Effectiveness of Vaccination in populations Excluded from iNitial Trials of COVID) study, a prospective, observational cohort study. Localized and systemic reactions were assessed via questionnaire. Disease flare was defined by worsening IBD symptoms and change in IBD medications. Outcomes were stratified by vaccine type and IBD medication classes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 3316 individuals with IBD received at least 1 COVID-19 vaccine. Injection site tenderness (68%) and fatigue (46% dose 1, 68% dose 2) were the most commonly reported localized and systemic AEs after vaccination. Severe localized and systemic vaccine-related AEs were rare. The mRNA-1273 vaccine was associated with significantly greater severe AEs at dose 2 (localized 4% vs 2%, systemic 15% vs 10%; P &amp;lt; .001 for both). Prior COVID-19 infection, female sex, and vaccine type were associated with severe systemic reactions to dose 1, while age &amp;lt;50 years, female sex, vaccine type, and antitumor necrosis factor and vedolizumab use were associated with severe systemic reactions to dose 2. Overall rates (2%) of IBD flare were low following vaccination.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Our findings provide reassurance that the severe acute respiratory syndrome coronavirus 2 vaccine is safe and well tolerated among individuals with IBD, which may help to combat vaccine hesitancy and increase vaccine confidence.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ibd\/izab302","type":"journal-article","created":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T20:21:20Z","timestamp":1638822080000},"page":"1497-1505","source":"Crossref","is-referenced-by-count":74,"title":["Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID"],"prefix":"10.1093","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7407-370X","authenticated-orcid":false,"given":"Kimberly N","family":"Weaver","sequence":"first","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina at Chapel Hill , Chapel Hill, NC , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Division of Pediatric Gastroenterology, Department of Pediatrics, University of North Carolina at Chapel Hill , Chapel Hill, NC , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangfeng","family":"Dai","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina at Chapel Hill , Chapel Hill, NC , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runa","family":"Watkins","sequence":"additional","affiliation":[{"name":"Division of Pediatric Gastroenterology and Nutrition, University of Maryland School of Medicine, Baltimore, MD , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Adler","sequence":"additional","affiliation":[{"name":"Susan B. Meister Child Health Evaluation and Research Center and Division of Pediatric Gastroenterology, University of Michigan , Ann Arbor, MI , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4968-5795","authenticated-orcid":false,"given":"Marla C","family":"Dubinsky","sequence":"additional","affiliation":[{"name":"Susan and Leonard Feinstein IBD Center, Department of Pediatrics, Icahn School of Medicine at Mount Sinai , New York, NY , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Kastl","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Children\u2019s Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania , Philadelphia, PA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athos","family":"Bousvaros","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Boston Children\u2019s Hospital , Boston, MA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A","family":"Strople","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Ann and Robert H. Lurie Children\u2019s Hospital of Chicago , Chicago, IL , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9766-5196","authenticated-orcid":false,"given":"Raymond K","family":"Cross","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, University of Maryland School of Medicine, Baltimore, MD , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter D R","family":"Higgins","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology & Hepatology, University of Michigan , Ann Arbor, MI , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan C","family":"Ungaro","sequence":"additional","affiliation":[{"name":"Susan and Leonard Feinstein IBD Center, Department of Medicine, Icahn School of Medicine at Mount Sinai , New York, NY , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenakshi","family":"Bewtra","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Perelman School of Medicine, University of Pennsylvania , Philadelphia PA , USA"},{"name":"Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania , Philadelphia PA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuelle","family":"Bellaguarda","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Northwestern University , Chicago, IL , USA and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis A","family":"Farraye","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic , Jacksonville, FL , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margie E","family":"Boccieri","sequence":"additional","affiliation":[{"name":"Division of Pediatric Gastroenterology, Department of Pediatrics, University of North Carolina at Chapel Hill , Chapel Hill, NC , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Firestine","sequence":"additional","affiliation":[{"name":"Division of Pediatric Gastroenterology, Department of Pediatrics, University of North Carolina at Chapel Hill , Chapel Hill, NC , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D","family":"Kappelman","sequence":"additional","affiliation":[{"name":"Division of Pediatric Gastroenterology, Department of Pediatrics, University of North Carolina at Chapel Hill , Chapel Hill, NC , USA"},{"name":"Center for Gastrointestinal Biology and Disease, University of North Carolina at Chapel Hill , Chapel Hill, NC , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Millie D","family":"Long","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina at Chapel Hill , Chapel Hill, NC , USA"},{"name":"Center for Gastrointestinal Biology and Disease, University of North Carolina at Chapel Hill , Chapel Hill, NC , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,12,6]]},"reference":[{"key":"2023112212505050900_CIT0001","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine.","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med."},{"key":"2023112212505050900_CIT0002","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine.","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med."},{"key":"2023112212505050900_CIT0003","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa2101544","article-title":"Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19.","volume":"384","author":"Sadoff","year":"2021","journal-title":"N Engl J Med."},{"key":"2023112212505050900_CIT0004","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/j.cgh.2021.02.004","article-title":"COVID-19 vaccination intent and perceptions among patients with inflammatory bowel diseases.","volume":"19","author":"Dalal","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2023112212505050900_CIT0005","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/ibd.21800","article-title":"Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease: a prospective study.","volume":"18","author":"Fiorino","year":"2012","journal-title":"Inflamm Bowel Dis."},{"key":"2023112212505050900_CIT0006","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/gutjnl-2011-300256","article-title":"Serological response to the 2009 H1N1 influenza vaccination in patients with inflammatory bowel disease.","volume":"61","author":"Cullen","year":"2012","journal-title":"Gut."},{"key":"2023112212505050900_CIT0007","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1093\/ecco-jcc\/jjv152","article-title":"Immunogenicity and safety of influenza vaccine in inflammatory bowel disease patients treated or not with immunomodulators and\/or biologics: a two-year prospective study.","volume":"9","author":"Launay","year":"2015","journal-title":"J Crohns Colitis."},{"key":"2023112212505050900_CIT0008","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1136\/gut.2010.233981","article-title":"H1N1 vaccines in a large observational cohort of patients with inflammatory bowel disease treated with immunomodulators and biological therapy.","volume":"60","author":"Rahier","year":"2011","journal-title":"Gut."},{"key":"2023112212505050900_CIT0009","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1007\/s10620-019-06016-4","article-title":"Safety of recombinant zoster vaccine in patients with inflammatory bowel disease.","volume":"65","author":"Satyam","year":"2020","journal-title":"Dig Dis Sci."},{"key":"2023112212505050900_CIT0010","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.14309\/ajg.0000000000001342","article-title":"Adverse events After SARS-CoV-2 mRNA vaccination among patients with inflammatory bowel disease.","volume":"116","author":"Botwin","year":"2021","journal-title":"Am J Gastroenterol."},{"key":"2023112212505050900_CIT0011","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1053\/j.gastro.2021.06.016","article-title":"Humoral immune response to messenger RNA COVID-19 vaccines among patients with inflammatory bowel disease.","volume":"161","author":"Kappelman","year":"2021","journal-title":"Gastroenterology."},{"key":"2023112212505050900_CIT0012","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1038\/ajg.2009.197","article-title":"The Manitoba IBD Index: evidence for a new and simple indicator of IBD activity.","volume":"104","author":"Clara","year":"2009","journal-title":"Am J Gastroenterol."},{"key":"2023112212505050900_CIT0013","doi-asserted-by":"crossref","first-page":"n308","DOI":"10.1136\/bmj.n308","article-title":"Covid-19: people who have had infection might only need one dose of mRNA vaccine.","volume":"372","author":"Wise","year":"2021","journal-title":"BMJ."},{"key":"2023112212505050900_CIT0014","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1056\/NEJMc2101667","article-title":"Antibody responses in seropositive persons after a single dose of SARS-CoV-2 mRNA vaccine.","volume":"384","author":"Krammer","year":"2021","journal-title":"N Engl J Med."},{"key":"2023112212505050900_CIT0015","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1053\/j.gastro.2021.06.014","article-title":"COVID-19 vaccination is safe and effective in patients withinflammatory bowel disease: analysis of a large multi-institutional research network in the United States.","volume":"161","author":"Hadi","year":"2021","journal-title":"Gastroenterology."},{"key":"2023112212505050900_CIT0016","first-page":"e60","article-title":"American college of rheumatology guidance for COVID-19 vaccination in patients with rheumatic and musculoskeletal diseases: version 3.","volume":"73","author":"Curtis","year":"2021","journal-title":"Arthritis Rheumatol."},{"key":"2023112212505050900_CIT0017","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1136\/gutjnl-2020-324000","article-title":"SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting.","volume":"70","author":"Siegel","year":"2021","journal-title":"Gut."}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/28\/10\/1497\/53679294\/izab302.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/28\/10\/1497\/53679294\/izab302.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T17:32:10Z","timestamp":1700674330000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/28\/10\/1497\/6454297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,6]]},"references-count":17,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,12,6]]},"published-print":{"date-parts":[[2022,10,3]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izab302","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,10,1]]},"published":{"date-parts":[[2021,12,6]]}}}